Current Trials available at Adelaide Oncology & Haematology

Tumour Type

Trial

  Principal    Investigator

   Title

Melanoma         

PISCES             

 Dr Rachel Roberts-Thomson

  A Multicentre Phase 2,    Open-Label Study of    Intratumoral   TavokinogeneTelseplasmid   (tavo, pIL-12)   plus Electroporation in   Combination with    Intravenous    Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressing on either Pembrolizumab or Nivolumab Treatment

TNBC                

OMS- I141      

  Dr Rohit Joshi

A phase 2, open-label study of intratumoural Tavokinogene Telseplasmid plus electroporation in combination with intravenous Pembrolizumab therapy in patients with inoperable locally advanced or metastatic triple negative breast cancer.

NSCLC

Pacific-R

 Dr Rohit Joshi

First real-world data on unresectable stage III NSCLC patients treated with Durvalumab after chemoradiotherapy (Retrospective data collection from patients treated with durvalumab via EAP)

Lymphoma  

Gilead      

 Dr Wilfrid Jaksic

Dose optimazation of Idelalisib in follicular lymphoma

TRIAL CURRENTLY ON HOLD  

AnyOral Chemotherapy Reminder

Dr Rohit Joshi

and PhD student

A smartphone text message self-management program to support adequate adherence to oral chemotherapy in AYA and adult cancer patients: Proof of concept
BladderCA017-078Dr Rohit JoshiA Phase 3, Randomized, study of neoadjuvant chemotherapy alone verses neoadjuvant chemotherapy plus Nivolumab or Nivolumab and BMS-986205, followed by continued post-surgery therapy with Nivolumab or Nivolumab and BMS-986205 in participants with muscle-invasive bladder cancer